FOXA3 and metabolic dysfunction-associated steatotic liver disease: Consistent with these data, overexpression of hepatic FOXA3 reduced hepatic hydroxyproline (Fig. 6K) and NAFLD activity score (Fig. 6L) in WT mice, but not in Tgr5−/− mice.